查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829367

2025年照护现场（POC）血液凝固检验全球市场报告

Point-of-Care (POC) Coagulation Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，即时血液凝固检验(POC) 市场呈现强劲成长照护现场，市场规模从 2024 年的 11.8 亿美元成长至 2025 年的 12.5 亿美元，复合年增长率为 5.4%。这段时期的成长归因于患者需求的不断增长、就地检验的普及趋势、凝血状态的高可靠性、自动化以及与电子健康记录(EHR) 的集成，以及心血管疾病和血液病患病率的不断上升。

预计未来几年照护现场(POC)血液凝固检验市场规模将稳定成长，到 2029 年将达到 14.7 亿美元，复合年增长率为 4.2%。预测期内的增长可归因于医疗保健领域应用的不断扩展、居家照护需求的不断增长、慢性血液病患病率的不断上升、患者对快速准确检测的需求以及就地检验的兴起。预测期内的主要发展趋势包括技术进步、已开发国家需求旺盛、医疗保健领域应用的不断扩展、新冠疫情 (COVID-19) 对新兴国家的影响以及 POC 诊断的多重化。

照护现场血液凝固检验(POC) 是一种诊断方法，无需在中心实验室，即可在患者或患者附近评估凝血功能。此检测通常可在几分钟内快速获得结果，使医护人员能够及时做出治疗决策并优化抗凝血治疗方案。

POC血液凝固检验的主要技术包括光学、机械和电化学。光学技术利用光来实现各种目的，例如资料传输、成像和感测。这些检测透过直接竞标和零售等管道分发给医院、诊所和居家医疗机构等最终用户。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司新报告系列的一部分，该系列提供了照护现场(POC)血液凝固检验血液凝固检验市场统计数据，包括全球市场规模、区域照护现场、照护现场(POC)血液凝固检验市场份额的竞争对手、照护现场(POC)血液凝固检验的详细细分市场、市场趋势和机会，以及在照护现场(POC)血液凝固检验行业取得成功所需的数据。这份照护现场(POC)血液凝固检验市场研究报告对该行业的当前和未来情况进行了详细分析，为您提供所需的一切的完整观点。

未来五年4.2%的预测成长率比我们先前对该市场的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会透过对主要来自瑞士和韩国的凝血活酶试剂和压电血凝检测感测器征收关税直接影响美国，从而提高快速血凝评估的成本。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

由于心血管疾病 (CVD) 盛行率的不断上升，预计照护现场(POC)血液凝固检验市场将会成长。 CVD 包括影响心臟和血管的各种疾病，例如心臟疾病和脑血管疾病。 POC血液凝固检验在 CVD 治疗中起着关键作用，它提供有关凝血状态的即时讯息，从而能够及时干预并降低出血併发症的风险，尤其是在心血管手术后。例如，2023 年 5 月，美国疾病管制与预防中心报告称，2021 年心臟病将在美国夺走约 69.5 万人的生命，占死亡人数的五分之一。心臟疾病是最常见的原因，在 2021 年造成 375,476 人死亡。心血管疾病盛行率的不断上升是支持 POC血液凝固检验市场成长的关键因素。

照护现场(POC)血液凝固检验市场由提供血液凝固检验服务、现场止血检测、照护现场服务和快速凝血分析的营业单位所获得的收益组成。市场价值包括服务提供者销售的或包含在其服务产品中的相关产品的价值。照护现场(POC)血液凝固检验市场还包括凝血分析仪、试纸、凝血酶原时间 (PT) 监测仪、D-二聚体检测设备和照护现场血液凝固检验套件的销售。该市场的价值是“出厂价”，即商品製造商或创造者出售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接出售给最终客户的商品价值。该市场中的商品价值还包括商品创造者出售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球照护现场（POC）血液凝固检验：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球照护现场（POC）血液凝固检验市场：成长率分析
  • 全球照护现场（POC）血液凝固检验市场表现：规模与成长，2019-2024
  • 全球照护现场（POC）血液凝固检验市场预测：规模与成长，2024-2029年，2034年预测
  • 全球照护现场（POC）血液凝固检验：总潜在市场（TAM）

第六章 市场细分

  • 全球照护现场（POC）血液凝固检验市场：按技术、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 光学技术
  • 机械工业
  • 电化学技术
  • 全球照护现场（POC）血液凝固检验市场：依通路、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 直接竞标
  • 零售
  • 全球照护现场（POC）血液凝固检验市场：依最终用户、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 居家护理
  • 全球照护现场（POC）血液凝固检验市场：按光学技术（类型）细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 反射率测量
  • 萤光侦测
  • 比色检测
  • 全球照护现场（POC）血液凝固检验市场：按机器技术（类型）、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 机械振动
  • 超音波检测
  • 全球照护现场（POC）血液凝固检验市场：按电化学技术（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 安培检测
  • 电位差检测
  • 电导率检测

第七章 区域和国家分析

  • 全球照护现场（POC）血液凝固检验市场：区域分析、预测与趋势，2019-2024 年、2024-2029 年、2034 年
  • 全球照护现场（POC）血液凝固检验市场：国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 照护现场（POC）血液凝固检验市场：竞争格局
  • 照护现场（POC）血液凝固检验市场：公司简介
    • AT&T Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Danaher Corporation
  • Medtronic Plc
  • Koninklijke Philips NV
  • Sysmex Corporation
  • IDEXX Laboratories Inc.
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Teleflex Incorporated
  • Werfen SA
  • Nihon Kohden Corporation
  • Horiba Ltd.
  • Hycel
  • Nova Biomedical Corporation
  • Haemonetics Corporation
  • Maccura Biotechnology Co. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年照护现场(POC)血液凝固检验市场：提供新机会的国家
  • 2029 年照护现场(POC)血液凝固检验市场：细分市场带来新机会
  • 2029 年照护现场(POC)血液凝固检验市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r28769u

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The point-of-care (POC) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (POC) coagulation testing market statistics, including point-of-care (POC) coagulation testing industry global market size, regional shares, competitors with a point-of-care (POC) coagulation testing market share, detailed point-of-care (POC) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (POC) coagulation testing industry. This point-of-care (POC) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (poc) coagulation testing market size has grown strongly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rise in patient demand, growing trend of point-of-care testing, high reliability of coagulation status on pt test, automation and integration with electronic health records (EHRs), rising incidence of cardiovascular diseases and blood disorders.

The point-of-care (poc) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to expanding applications in healthcare, rising demand in homecare settings, increased prevalence of chronic blood disorders, patient demand for rapid and accurate testing, rise in point-of-care testing. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, COVID-19 impact, multiplexing POC diagnostics.

The forecast of 4.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on thromboplastin reagents and piezoelectric clot detection sensors, largely sourced from Switzerland and South Korea, raising expenses for rapid blood clotting assessments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The point-of-care (POC) coagulation testing market is expected to grow due to the increasing incidence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease and cerebrovascular disease. POC coagulation testing plays a crucial role in CVD treatment by providing real-time information on coagulation status, enabling timely interventions and reducing the risk of bleeding complications, particularly after cardiac surgery. For example, in May 2023, the Centers for Disease Control and Prevention reported that heart disease claimed about 695,000 lives in the United States in 2021, accounting for 1 in 5 deaths. Coronary heart disease, the most common type, caused 375,476 deaths in 2021. This increasing prevalence of cardiovascular diseases is a key driver behind the growth of the POC coagulation testing market.

Major companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to enhance their competitive position. These collaborations involve formal agreements between two or more parties to work towards specific, mutually beneficial goals. For example, in October 2021, Trivitron Healthcare partnered with Diagon Ltd. and Vanguard Diagnostics to introduce Coagulation Analyzer products. These analyzers offer precise and efficient coagulation testing, with the collaboration aimed at enhancing patient diagnosis and management. The range of analyzers is designed to cater to various healthcare settings, making coagulation testing more accessible.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care (poc) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care (poc) coagulation testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care (poc) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Optical Technology; Mechanical Technology; Electrochemical Technology
  • 2) By Distribution Channel: Direct Tenders; Retail
  • 3) By End-User: Hospitals; Clinics; Home care
  • Subsegments:
  • 1) By Optical Technology: Reflectance Photometry; Fluorescence Detection; Colorimetric Detection
  • 2) By Mechanical Technology: Mechanical Oscillation; Ultrasonic Detection
  • 3) By Electrochemical Technology: Amperometric Detection; Potentiometric Detection; Conductometric Detection
  • Companies Mentioned: AT&T Corporation; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Danaher Corporation; Medtronic Plc; Koninklijke Philips N.V.; Sysmex Corporation; IDEXX Laboratories Inc.; Quidel Corporation; Bio-Rad Laboratories Inc.; Teleflex Incorporated; Werfen SA; Nihon Kohden Corporation; Horiba Ltd.; Hycel; Nova Biomedical Corporation; Haemonetics Corporation; Maccura Biotechnology Co. Ltd.; Helena Laboratories Corporation; Abaxis Inc.; ARKRAY Inc.; Radiometer Medical ApS; HemoSonics LLC; iLine Microsystems SL; Corgenix Medical Corporation; Quotient Limited; Micropoint Bioscience Inc.; Beijing Succeeder Technology Inc.; EKF Diagnostics Holdings plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point-of-Care (POC) Coagulation Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point-of-Care (POC) Coagulation Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point-of-Care (POC) Coagulation Testing Market Growth Rate Analysis
  • 5.4. Global Point-of-Care (POC) Coagulation Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point-of-Care (POC) Coagulation Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point-of-Care (POC) Coagulation Testing Total Addressable Market (TAM)

6. Point-of-Care (POC) Coagulation Testing Market Segmentation

  • 6.1. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • 6.2. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tenders
  • Retail
  • 6.3. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home care
  • 6.4. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Optical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reflectance Photometry
  • Fluorescence Detection
  • Colorimetric Detection
  • 6.5. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Mechanical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Oscillation
  • Ultrasonic Detection
  • 6.6. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Electrochemical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amperometric Detection
  • Potentiometric Detection
  • Conductometric Detection

7. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care (POC) Coagulation Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point-of-Care (POC) Coagulation Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

  • 8.1. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-of-Care (POC) Coagulation Testing Market

  • 9.1. China Point-of-Care (POC) Coagulation Testing Market Overview
  • 9.2. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-of-Care (POC) Coagulation Testing Market

  • 10.1. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-of-Care (POC) Coagulation Testing Market

  • 11.1. Japan Point-of-Care (POC) Coagulation Testing Market Overview
  • 11.2. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-of-Care (POC) Coagulation Testing Market

  • 12.1. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-of-Care (POC) Coagulation Testing Market

  • 13.1. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-of-Care (POC) Coagulation Testing Market

  • 14.1. South Korea Point-of-Care (POC) Coagulation Testing Market Overview
  • 14.2. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-of-Care (POC) Coagulation Testing Market

  • 15.1. Western Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 15.2. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-of-Care (POC) Coagulation Testing Market

  • 16.1. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-of-Care (POC) Coagulation Testing Market

  • 17.1. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-of-Care (POC) Coagulation Testing Market

  • 18.1. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-of-Care (POC) Coagulation Testing Market

  • 19.1. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-of-Care (POC) Coagulation Testing Market

  • 20.1. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

  • 21.1. Eastern Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-of-Care (POC) Coagulation Testing Market

  • 22.1. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-of-Care (POC) Coagulation Testing Market

  • 23.1. North America Point-of-Care (POC) Coagulation Testing Market Overview
  • 23.2. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-of-Care (POC) Coagulation Testing Market

  • 24.1. USA Point-of-Care (POC) Coagulation Testing Market Overview
  • 24.2. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-of-Care (POC) Coagulation Testing Market

  • 25.1. Canada Point-of-Care (POC) Coagulation Testing Market Overview
  • 25.2. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-of-Care (POC) Coagulation Testing Market

  • 26.1. South America Point-of-Care (POC) Coagulation Testing Market Overview
  • 26.2. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-of-Care (POC) Coagulation Testing Market

  • 27.1. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-of-Care (POC) Coagulation Testing Market

  • 28.1. Middle East Point-of-Care (POC) Coagulation Testing Market Overview
  • 28.2. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-of-Care (POC) Coagulation Testing Market

  • 29.1. Africa Point-of-Care (POC) Coagulation Testing Market Overview
  • 29.2. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape
  • 30.2. Point-of-Care (POC) Coagulation Testing Market Company Profiles
    • 30.2.1. AT&T Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Medtronic Plc
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Sysmex Corporation
  • 31.5. IDEXX Laboratories Inc.
  • 31.6. Quidel Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Werfen SA
  • 31.10. Nihon Kohden Corporation
  • 31.11. Horiba Ltd.
  • 31.12. Hycel
  • 31.13. Nova Biomedical Corporation
  • 31.14. Haemonetics Corporation
  • 31.15. Maccura Biotechnology Co. Ltd.

32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

34. Recent Developments In The Point-of-Care (POC) Coagulation Testing Market

35. Point-of-Care (POC) Coagulation Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Point-of-Care (POC) Coagulation Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care (POC) Coagulation Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care (POC) Coagulation Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer